Recent News
Determining the Exposure Limit for Asbestos
The Occupational Safety and Health Administration (OSHA) has maintained that “there is no ‘safe’ level of asbestos exposure for any type of asbestos fiber,” but despite these warnings, asbestos is[…]
Funding Needed for Lung Cancer Awareness and Research – How You Can Help
For a cancer than claims more lives than breast, colon, and prostate cancer combined, Lung Cancer is severely underfunded, leaving scientists and researchers reliant on private funding and donations. Funding[…]
Dealing With a Mesothelioma Diagnosis
A mesothelioma diagnosis is devastating for those suffering with the disease and family members alike. The nature of the illness is aggressive, and there is currently no cure. The quality[…]
Acupuncture as Potential Palliative Care for Mesothelioma Patients
When one thinks of acupuncture, one may envision a nice relaxing trip to a day spa, where after a long massage or a relaxing facial, tension in body can be[…]
Quality of Life After Pleurectomy/Decortication vs. Extra Pleural Pneumonectomy
On the rare instance that mesothelioma is diagnosed in the early stages of the disease, patients have the option for surgery. There are several surgical procedures used to treat mesothelioma.[…]
Phase 1 Clinical Trial For Those With Peritoneal Mesothelioma Underway
Mesothelioma is a rare cancer affecting only about 3,000 Americans each year. Most of those diagnosed are diagnosed with pleural mesothelioma, but a small number (approx. 500 per year) are[…]
Decade Long Study Reveals Potential for Early Detection in Mesothelioma
For many patients who are suffering from malignant mesothelioma, their diagnosis came quickly after experiencing symptoms. In many cases, this is because symptoms of mesothelioma typically do not appear until[…]
Researchers Theorize Drug from the 1800s Could Improve Radiation Treatments in Mesothelioma Patients
Radiation therapy for those suffering from mesothelioma is not typically the first line of treatment because of its overall effectiveness. High-energy x-rays, gamma rays, and neutrons that make up radiation[…]
Phase III Clinical Trial for Nintedanib Discontinued After Yielding Negative Results
Disappointing results from the LUME-Phase III clinical trial regarding nintedanib is a setback for scientists and researchers who were hopeful they were on the brink of finding a new, first[…]
Mesothelioma Awareness Day is September 26, 2018
Mesothelioma Awareness Day will once again take place on September 26, marking 15 consecutive years of awareness aimed to educate and inform society about the deadly cancer caused by exposure[…]
Skip to content